Yıl: 2018 Cilt: 28 Sayı: 1 Sayfa Aralığı: 119 - 123 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Serebral Vazospazm: Klinik İzlem ve Tedavi

Öz:
Subaraknoid kanama (SAK) sonrası gelişen fokal serebral iskeminin başlıca nedeni serebral vazospazmdır. Klinik olarak diğer iskemik inmelerden farkı, ortaya çıkmasının öngörülebilirliği, önlenebilirliği ve tedavi edilebilirliğidir. Anevrizma kanamasından sonra gelişen en korkutucu komplikasyon tekrar kanama iken, erken cerrahinin yaygın olarak uygulanır olması sayesinde bu sorunun önemi giderek azalmış ve vazospazm SAK'nın mortalite ve morbidite açısından en riskli komplikasyonu haline gelmiştir. Bu nedenle, vazospazmın erken tanınması hayati önem taşımaktadır. Anevrizmal SAK geçirmiş hastalarda vazospazm gelişmesini önleyecek tedbirleri almak, özellikle vazospazm açısından en riskli günlerde hastayı çok yakından izlemek ve en ufak bir kuşkuda enerjik bir tedavi ile müdahale etmek, vazospazma bağlı mortalite ve morbiditeyi azaltmanın birinci şartıdır. Bu derlemede, serebral vazospazmın klinik seyri ve güncel tedavisi özetlenmiştir
Anahtar Kelime:

Konular: Tıbbi Araştırmalar Deneysel Hematoloji Pediatri

Cerebral Vasospasm: Clinical Monitoring and Treatment

Öz:
The main cause of focal cerebral ischemia following subarachnoid hemorrhage (SAH) is cerebral vasospasm. Unlike other ischemic strokes, cerebral vasospasm can be clinically predicted, prevented and treated. The most dangerous complication following SAH is used to be considered as re-bleeding but its incidence and importance have decreased with the common use of early surgery. On the other hand, cerebral vasospasm has become the most dangerous complication of SAH by means of its mortality and morbidity. Therefore, the early recognition of cerebral vasospasm has utmost importance. Using preventive methods, close monitoring of the patients during the period of increased vasospasm risk after aneurysmal SAH, and starting aggressive treatment upon the slightest suspicion are the key to reducing vasospasm-related morbidity and mortality. In this review, we aimed to summarize the clinical course and current treatment options of cerebral vasospasm
Anahtar Kelime:

Konular: Tıbbi Araştırmalar Deneysel Hematoloji Pediatri
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Akinci IO, Sencer A, Basel A, Aras Y, Aydoseli A, Kamar C, Güresti E, Sencer S, Aydın K, Izgi N, Kiris T: Effect of lumbar puncture in patients with aneurysmal subarachnoid hemorrhage treated microsurgically or endovascularly. Acta Neurochir Suppl 115: 95-98, 2013
  • 2. Barker FG II, Ogilvy CS: Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: A meta-analysis. J Neurosurg 84: 405-414, 1996
  • 3. Bejjani GK, Bank WO, Olan WJ, Sekhar LN: The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 42: 979-986, 1998
  • 4. Cross DT 3rd, Moran CJ, Angtuaco EE, Milburn JM, Diringer MN, Dacey RG Jr: Intracranial pressure monitoring during intraarterial papaverine infusion for cerebral vasospasm. AJNR Am J Neuroradiol 19(7): 1319-1323, 1998
  • 5. Dorsch NWC: A review of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Part II: Management. J Clin Neurosci 1: 78-92, 1994
  • 6. Dorsch NWC: Incidence, effects and treatment of ischemia following aneurysm rupture. Sano K, Takakura K, Kassell NF and Sasaki T (eds), Cerebral Vasospasm, Tokyo: Univ. of Tokyo Press, 1990:495-498
  • 7. Ecker A, Riemenschneider PA: Arteriographic demonstration of spasm of the intracranial arteries: With special reference to saccular aneurysms. J Neurosurg 64: 594-600, 1986
  • 8. Eskridge JM, McAuliffe W, Song JK, Deliganis AV, Newell DW, Lewis DH, Mayberg MR, Winn HR: Balloon angioplasty for the treatment of vasospasm: Results of first 50 cases. Neurosurgery 42: 510-516, 1998
  • 9. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6: 1-9, 1980
  • 10. Fujii Y, Takahashi A, Yoshimoto T: Effect of balloon angioplasty on high grade symptomatic vasospasm after subarachnoid hemorrhage. Neurosurg Rev 18: 7-13, 1995
  • 11. Hamilton MG, Williams FC: Perioperative management of subarachnoid hemorhage. Carter LP, Spetzler R (ed), Neurovascular Surgery, New York: Mc-Graw-Hill, 1995:603- 624
  • 12. Hasan D, Vermeulen M, Wijdicks EF, Hijdra A, van Gijn J: Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage. Stroke 20(11): 1511-1515, 1989
  • 13. Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP: The international cooperative study on timing of aneurysm surgery. Part 1: Overall management results. J Neurosurg 73: 18-37, 1990
  • 14. Kistler JP, Crowell RM, Davis KR, Heros R, Ojemann RG, Zervas T, Fisher CM: The relation of cerebral vasospasm to the extentand location of subarachnoid blood visualized by CT scan: A prospective study. Neurology 33: 424-436, 1983
  • 15. Klimo P Jr, Kestle JR, MacDonald JD, Schmidt RH: Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 100: 215-224, 2004
  • 16. Macdonald RL, Weir B: Cerebral Vasospasm. San Diego: Academic Press 2001: 387-389
  • 17. McAuliffe W, Townsend M, Eskridge JM, Newell DW, Grady MS, Winn HR: Intracranial pressure changes induced during papaverine infusion for treatment of vasospasm. J Neurosurg 83(3): 430-434, 1995
  • 18. Milburn JM, Moran CJ, Cross DT 3rd, Diringer MN, Pilgram TK, Dacey RG Jr: Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration. J Neurosurg 88(1): 38-42, 1998
  • 19. Mori T, Katayama Y, Kawamata T, Hirayama T: Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 91(6): 947-952, 1999
  • 20. Numaguchi Y, Zoarski GH, Clouston JE, Zagardo MT, Simard JM, Aldrich EF, Sloan MA, Maurer PK, Okawara SH: Repeat intra-arterial papaverine for recurrent cerebral vasospasm after subarachnoid haemorrhage. Neuroradiology 39(10): 751- 759, 1997
  • 21. Origitano TC, Wascher TM, Reichman OH, Anderson DE: Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage. Neurosurgery 27:729-739, 1990
  • 22. Pluta RM, Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald RL, Nishizawa S, Kasuya H, Wellman G, Keller E, Zauner A, Dorsch N, Clark J, Ono S, Kiris T, Leroux P, Zhang JH: Cerebral vasospasm following subarachnoid hemorrhage: Time for a new world of thought. Neurol Res 31(2):151-158, 2009
  • 23. Ropper AH, Gress DR, Diringer MN, Green DM, Mayer SA, Bleck TP: Neurological and neurosurgical intensive care, 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2004: 391
  • 24. Rordorf G, Koroshetz WJ, Copen WA, Gonzalez G, Yamada K, Schaefer PW, Schwamm LH, Ogilvy CS, Sorensen AG: Diffusion- and perfusion-weighted imaging in vasospasm after subarachnoid hemorrhage. Stroke 30(3): 599-605, 1999
  • 25. Sencer S, Kırıs T, Sencer A, Yaka U, Sahinbas M, Aydın K, Tiryaki B, Karasu A, Agus O, Ozkan M, Imer M, Unal F: Diffusion and perfusion MRI findings with clinical correlation in patients with subarachnoid haemorrhage related vasospasm. Acta Neurochir Suppl 104: 245-248, 2008
  • 26. Sloan MA, Haley EC Jr, Kassell NF, Henry ML, Stewart SR, Beskin RR, Sevilla EA, Torner JC: Sensitivity and specificity of transcranial Doppler ultrasonography in the diagnosis of vasospasm following subarachnoid hemorrhage. Neurology 39(11): 1514-1518, 1989
  • 27. Sloan MA, Burch CM, Wozniak MA, Rothman MI, Rigamonti D, Permutt T, Numaguchi Y: Transcranial doppler detection of vertebrobasilar vasospasm following subarachnoid hemorrhage. Stroke 25(11): 2187-2197, 1994
  • 28. Solomon RA, Fink ME, Lennihan L: Early aneurysm surgery and prophylactic hypervolemic hypertensive therapy for the treatment of aneurysmal subarachnoid hemorrhage. Neurosurgery 23(6): 699-704, 1988
  • 29. Song JK, Elliott JP, Eskridge JM: Neuroradiologic diagnosis and treatment of vasospasm. Neuroimaging Clin N Am 7: 819- 835, 1997
  • 30. Stober T, Anstätt T, Sen S, Schimrigk K, Jäger H: Cardiac arrhythmias in subarachnoid haemorrhage. Acta Neurochir (Wien) 93(1-2): 37-44, 1988
  • 31. Taneda M: Effect of early operation for ruptured aneurymsms on prevention of late ischemic symptoms. J Neurosurg 57: 622-628, 1982
  • 32. Weir B, Macdonald RL: Intracranial aneurysms and subarachnoid hemorrhage: An overview. In: Wilkins RH and Rengachary SS (eds), Neurosurgery. New York: McGraw Hill, 1996: 2191-2214
  • 33. Wijdicks EF, Ropper AH, Hunnicutt EJ, Richardson GS, Nathanson JA: Atrial natriuretic factor and salt wasting after aneurysmal subarachnoid hemorrhage. Stroke 22(12): 1519- 1524, 1991
  • 34. Wijdicks EF, Vermeulen M, Hijdra A, van Gijn J: Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: Is fluid restriction harmful? Ann Neurol 17(2): 137- 140, 1985
  • 35. Zabramski JM, Spetzler RF, Bonstelle C: Chronic cerebral vasospasm: Effect of volume and timing of hemorrhage in a canine model. Neurosurgery 18: 1-6, 1986
APA Goker B, AKÇAKAYA M, HAMAMCIOĞLU M, KIRIS T (2018). Serebral Vazospazm: Klinik İzlem ve Tedavi. , 119 - 123.
Chicago Goker Burcu,AKÇAKAYA M Osman,HAMAMCIOĞLU M. Kemal,KIRIS TALAT Serebral Vazospazm: Klinik İzlem ve Tedavi. (2018): 119 - 123.
MLA Goker Burcu,AKÇAKAYA M Osman,HAMAMCIOĞLU M. Kemal,KIRIS TALAT Serebral Vazospazm: Klinik İzlem ve Tedavi. , 2018, ss.119 - 123.
AMA Goker B,AKÇAKAYA M,HAMAMCIOĞLU M,KIRIS T Serebral Vazospazm: Klinik İzlem ve Tedavi. . 2018; 119 - 123.
Vancouver Goker B,AKÇAKAYA M,HAMAMCIOĞLU M,KIRIS T Serebral Vazospazm: Klinik İzlem ve Tedavi. . 2018; 119 - 123.
IEEE Goker B,AKÇAKAYA M,HAMAMCIOĞLU M,KIRIS T "Serebral Vazospazm: Klinik İzlem ve Tedavi." , ss.119 - 123, 2018.
ISNAD Goker, Burcu vd. "Serebral Vazospazm: Klinik İzlem ve Tedavi". (2018), 119-123.
APA Goker B, AKÇAKAYA M, HAMAMCIOĞLU M, KIRIS T (2018). Serebral Vazospazm: Klinik İzlem ve Tedavi. Türk Nöroşirürji Dergsi, 28(1), 119 - 123.
Chicago Goker Burcu,AKÇAKAYA M Osman,HAMAMCIOĞLU M. Kemal,KIRIS TALAT Serebral Vazospazm: Klinik İzlem ve Tedavi. Türk Nöroşirürji Dergsi 28, no.1 (2018): 119 - 123.
MLA Goker Burcu,AKÇAKAYA M Osman,HAMAMCIOĞLU M. Kemal,KIRIS TALAT Serebral Vazospazm: Klinik İzlem ve Tedavi. Türk Nöroşirürji Dergsi, vol.28, no.1, 2018, ss.119 - 123.
AMA Goker B,AKÇAKAYA M,HAMAMCIOĞLU M,KIRIS T Serebral Vazospazm: Klinik İzlem ve Tedavi. Türk Nöroşirürji Dergsi. 2018; 28(1): 119 - 123.
Vancouver Goker B,AKÇAKAYA M,HAMAMCIOĞLU M,KIRIS T Serebral Vazospazm: Klinik İzlem ve Tedavi. Türk Nöroşirürji Dergsi. 2018; 28(1): 119 - 123.
IEEE Goker B,AKÇAKAYA M,HAMAMCIOĞLU M,KIRIS T "Serebral Vazospazm: Klinik İzlem ve Tedavi." Türk Nöroşirürji Dergsi, 28, ss.119 - 123, 2018.
ISNAD Goker, Burcu vd. "Serebral Vazospazm: Klinik İzlem ve Tedavi". Türk Nöroşirürji Dergsi 28/1 (2018), 119-123.